Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension

In total, 62patients with mild to moderate arterial hypertension underwent echocardiography and Doppler cardiography. For 12 weeks, all participants received spirapril, 6 mg/d. Spirapril therapy was associated with reduced left ventricular hypertrophy and pathological heart remodeling type number.

Bibliographic Details
Main Authors: M. M. Beraya, V. V. Petriy, V. I. Buvaltsev, N. G. Sergushkina, V. I. Makolkin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2007-02-01
Series:Российский кардиологический журнал
Subjects:
arterial hypertension
remodeling
left ventricular hypertrophy
spirapril
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2031

Similar Items

Similar Items